Literature DB >> 26910794

Pharmacokinetics of rosuvastatin in 30 healthy Zimbabwean individuals of African ancestry.

Nyarai Soko1,2, Collet Dandara3, Raj Ramesar1, Gerard Kadzirange4, Collen Masimirembwa2,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26910794      PMCID： PMC4917814          DOI： 10.1111/bcp.12915

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based method.

Authors:  Eleni Aklillu; Sabina Mugusi; Eliford Ngaimisi; Michael Marcus Hoffmann; Sonja König; Victoria Ziesenitz; Gerd Mikus; Walter Emil Haefeli; Johanna Weiss
Journal:  Eur J Clin Pharmacol       Date:  2011-06-01       Impact factor: 2.953

2.  Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States.

Authors:  Bruce K Birmingham; Sarah R Bujac; Robert Elsby; Connie T Azumaya; Julie Zalikowski; Yusong Chen; Kenneth Kim; Helen J Ambrose
Journal:  Eur J Clin Pharmacol       Date:  2015-01-30       Impact factor: 2.953

3.  Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males.

Authors:  Wei Zhang; Bang-Ning Yu; Yi-Jing He; Lan Fan; Qing Li; Zhao-Qian Liu; An Wang; Ya-Li Liu; Zhi-Rong Tan; Yuan-Fei Huang; Hong-Hao Zhou
Journal:  Clin Chim Acta       Date:  2006-05-13       Impact factor: 3.786

4.  Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment.

Authors:  Edmund Lee; Stephen Ryan; Bruce Birmingham; Julie Zalikowski; Ruth March; Helen Ambrose; Rachael Moore; Caroline Lee; Yusong Chen; Dennis Schneck
Journal:  Clin Pharmacol Ther       Date:  2005-10       Impact factor: 6.875

5.  SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.

Authors:  Marja K Pasanen; Mikko Neuvonen; Pertti J Neuvonen; Mikko Niemi
Journal:  Pharmacogenet Genomics       Date:  2006-12       Impact factor: 2.089

6.  Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers.

Authors:  Paul D Martin; Mike J Warwick; Aaron L Dane; Steve J Hill; Petrina B Giles; Paul J Phillips; Eva Lenz
Journal:  Clin Ther       Date:  2003-11       Impact factor: 3.393

7.  Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations.

Authors:  Eliford Ngaimisi; Abiy Habtewold; Omary Minzi; Eyasu Makonnen; Sabina Mugusi; Wondwossen Amogne; Getnet Yimer; Klaus-Dieter Riedel; Mohammed Janabi; Getachew Aderaye; Ferdinand Mugusi; Leif Bertilsson; Eleni Aklillu; Juergen Burhenne
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240
  7 in total
  4 in total

1.  Pharmacokinetics of Rosuvastatin: A Systematic Review of Randomised Controlled Trials in Healthy Adults.

Authors:  Raju Kanukula; Abdul Salam; Anthony Rodgers; Bishoy Kamel
Journal:  Clin Pharmacokinet       Date:  2021-01-11       Impact factor: 6.447

2.  Comparison of Lipid Profile, Liver Enzymes, Creatine Kinase and Lactate Dehydrogenase Among Type II Diabetes Mellitus Patients on Statin Therapy.

Authors:  Mezgebu Legesse Habte; Daniel Seifu Melka; Maria Degef; M K C Menon; Helen Yifter; Teka Obsa Feyisa
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-18       Impact factor: 3.168

3.  African Pharmacogenomics Consortium: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa.

Authors:  Collet Dandara; Collen Masimirembwa; Yosr Z Haffani; Bernhards Ogutu; Jenniffer Mabuka; Eleni Aklillu; Oluseye Bolaji
Journal:  AAS Open Res       Date:  2019-06-04

4.  A cost effective RFLP method to genotype Solute carrier organic anion 1B1 (SLCO1B1) c.1929A>C (p.Leu643Phe, rs34671512); a variant with potential effect on rosuvastatin pharmacokinetics.

Authors:  Nyarai D Soko; Collen Masimirembwa; Collet Dandara
Journal:  BMC Res Notes       Date:  2018-06-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.